Nurse Practitioner

Nurse Practitioner
Audio Summaries

The literature in nurse practitioner doesn't slow down, and the papers you skip might be the ones that change your practice. OSLR turns the journals you'd read if you had the time into 3-minute audio summaries. Listen on your commute, between cases, whenever.

18 active journals623 audio summaries

Recent summaries

The latest articles summarized from nurse practitioner journals.

Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma

The New England journal of medicine|Sep 23, 2026

This phase 1 study investigates the safety and efficacy of anitocabtagene autoleucel (anito-cel), a BCMA-directed CAR T-cell therapy, in patients with relapsed or refractory multiple myeloma who have undergone multiple prior treatments. The results indicate a high response rate (100%) with a significant proportion achieving complete response (79%), while adverse events, particularly cytokine release syndrome and neurotoxicity, were mostly mild. The findings suggest that anito-cel may be a promising treatment option for this challenging patient population.

Clinical Uses of Common Genetic Variants Associated with Common Diseases

The New England journal of medicine|Sep 23, 2026

The authors investigate why the integration of polygenic risk scores and genomic knowledge into clinical practice for common adult-onset diseases has been slow, despite advancements in genomics and the identification of numerous genetic variants associated with these conditions. They explore potential applications of these scores and pharmacogenomics in improving prevention and treatment strategies as genome sequencing becomes more accessible.

Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome

The New England journal of medicine|Sep 23, 2026

This study investigates the efficacy and safety of etuvetidigene autotemcel (etu-cel), an autologous gene therapy, for treating Wiskott-Aldrich syndrome, a rare genetic disorder. The results indicate a high overall survival rate of 96% at both 1 and 5 years post-treatment, along with a significant reduction in severe infections and bleeding events after therapy. The findings suggest that etu-cel provides a sustained clinical benefit for patients with this condition.

Age-Associated Cognitive Deviations in Early-Onset Psychosis Patients and Their Siblings

The American journal of psychiatry|Sep 23, 2026

This study aimed to investigate cognitive impairments and age-associated cognitive deviations in children and adolescents with early-onset psychosis (EOP), their siblings, and nonpsychotic psychiatric controls. The findings revealed that nonaffective EOP probands exhibited impairments across all cognitive measures, while affective EOP probands showed impairments in most areas, with siblings demonstrating no impairments. The results suggest that targeted early interventions may help mitigate cognitive deviations, although longitudinal studies are necessary to validate these cross-sectional findings.

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis

The New England journal of medicine|Sep 23, 2026

The authors aimed to determine whether screening with a multicancer early-detection test, in addition to usual care, reduces the incidence of late-stage cancers (stage III or IV) compared to usual care alone. In a randomized controlled trial involving over 142,000 participants, they found no significant difference in the incidence rates of stage III or IV cancers between the two groups after three screening rounds. While there was a trend towards a lower incidence of stage IV cancers, the results were not conclusive, indicating the need for further follow-up.

Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial

JAMA|Sep 23, 2026

The study aimed to determine whether intravenous tenecteplase administered before endovascular thrombectomy (EVT) improves outcomes in patients with moderate to severe basilar artery occlusion presenting 4.5 to 24 hours after stroke onset. The findings revealed no significant difference in functional independence or safety outcomes between the tenecteplase plus EVT group and the EVT alone group, suggesting that the addition of tenecteplase does not enhance recovery in this patient population.

Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act

JAMA|Sep 21, 2026

This study aimed to compare kidney transplant and wait-listing rates between Medicare Advantage and traditional Medicare beneficiaries with end-stage kidney disease (ESKD) following the 21st Century Cures Act. The findings revealed that Medicare Advantage enrollees had significantly lower rates of both kidney transplants and incident wait-listing compared to those in traditional Medicare, highlighting potential disparities in access to this critical treatment. The authors suggest that policy oversight may be necessary to ensure equitable access to kidney transplants for the growing Medicare Advantage population.

Vaccines for Cancer: A Translational Science Review

JAMA|Sep 21, 2026

This review examines the advancements in cancer vaccine development, driven by improved understanding of tumor immunology and vaccine technology, and aims to assess the potential of these vaccines in treating various cancers. The authors highlight the mechanisms of action, types of antigens used, and the integration of cancer vaccines with other therapies, while also noting the generally mild adverse effects associated with these vaccines. Ultimately, the review emphasizes the ongoing clinical trials exploring the role of cancer vaccines in both treatment and primary prevention of cancer.

Epilepsy After Antipsychotic Prescription in Survivors of Traumatic Brain Injury: A Population-Based Cohort Study

Critical care medicine|Sep 21, 2026

The authors aimed to determine whether the choice of antipsychotic medication following hospitalization for traumatic brain injury (TBI) is linked to the risk of developing post-traumatic epilepsy in older adults. Their retrospective cohort study found no significant difference in epilepsy risk between those prescribed haloperidol or risperidone compared to quetiapine, although high mortality rates in the cohort may affect the reliability of these findings. Further research is suggested to confirm these results.

Intrauterine Mepivacaine Instillation vs Placebo for Pain During IUD Placement: A Randomized Clinical Trial

JAMA|Sep 17, 2026

This study aimed to determine whether intrauterine instillation of mepivacaine reduces pain during IUD placement in nulliparous individuals. The results showed that mepivacaine significantly decreased pain scores compared to a placebo, with 98.3% of participants in the mepivacaine group reporting tolerable pain, indicating that this local anesthetic may enhance the procedural experience for patients.

Start listening to nurse practitioner research

14-day free trial. Pick your journals and go.